SCHEMBL4068905

SCHEMBL4068905

CC(C)(C)OC(=O)NCCCC1CCSCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.51
EPHX1 P07099 1/20 0.50
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
GAA P10253 1/20 0.49
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
CA12 O43570 4/20 0.43
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
CA9 Q16790 4/20 0.43
ALDH1A1 P00352 1/20 0.39
FPR3 P25089 2/20 0.38
FPR2 P25090 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
SIRT3 Q9NTG7 1/20 0.38
MAN2B1 O00754 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4077144 0.89 TDP1 (0.59) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL4072834 0.86 EPHX1 (0.57) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL4073139 0.84 EPHX1 (0.60) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL16023429 0.82 TDP1 (0.51) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL4071347 0.82 TDP1 (0.51) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL18256901 0.80 EPHX1 (0.51) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL6243164 0.79 TDP1 (0.59) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL12648114 0.79 EPHX1 (0.55) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL9141341 0.78 TDP1 (0.48) TDP1EPHX1KMT2AMEN1GAA
SCHEMBL28484370 0.78 MEN1 (0.49) TDP1EPHX1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038041-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER Myriad Genetics, Inc. (US) 2009-03-25 EP disclosed
WO-2007134298-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER MYRIAD GENETICS, INC. (US) 2007-11-22 WO disclosed